-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
InMed Pharmaceuticals Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
- InMed Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $18.3K, a 74.1% decline year-over-year.
- InMed Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $134K, a 76% decline year-over-year.
- InMed Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2023 was $278K, a 60.1% decline from 2022.
- InMed Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2022 was $698K, a 14.4% increase from 2021.
- InMed Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2021 was $610K, a 38.6% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)